Latest News in the pharma Industry

Policy & Regulation

Pfizer refutes the findings set out in the CMA decision

Pfizer refutes the findings set out in the CMA decision

8 Dec 2016

Pharma giant says it complied with established competition law.

Read more 
FDA approves Jardiance tablets to reduce the risk of cardiovascular death in adults with T2D

FDA approves Jardiance tablets to reduce the risk of cardiovascular death in adults with T2D

5 Dec 2016

The only oral T2D medicine to provide a life-saving cardiovascular benefit.

Read more 
GSK's Relvar Ellipta gains approval in Japan for COPD patients

GSK's Relvar Ellipta gains approval in Japan for COPD patients

3 Dec 2016

Read more 
FDA accepts BLA for avelumab for the treatment of metastatic MCC for Priority Review

FDA accepts BLA for avelumab for the treatment of metastatic MCC for Priority Review

29 Nov 2016

If approved by the FDA, avelumab could be the first treatment indicated for patients with metastatic Merkel cell carcinoma.

Read more 
European Commission approves BMS's Opdivo for Hodgkin's

European Commission approves BMS's Opdivo for Hodgkin's

24 Nov 2016

Opdivo is now the first and only PD-1 inhibitor approved for a hematologic malignancy in the European Union.

Read more 
NICE ‘yes’ to Imnovid in the fight against the biggest blood cancer killer in the UK

NICE ‘yes’ to Imnovid in the fight against the biggest blood cancer killer in the UK

23 Nov 2016

Pomalidomide available to people in England immediately via the Cancer Drugs Fund.

Read more 
FDA gives green light to Sanofi's once-daily Soliqua 100/33

FDA gives green light to Sanofi's once-daily Soliqua 100/33

22 Nov 2016

The type 2 diabetes treatment for adults will be delivered using SoloStar technology.

Read more 
Allergan receives FDA clearance for the XEN Gel Stent

Allergan receives FDA clearance for the XEN Gel Stent

22 Nov 2016

The XEN Glaucoma Treatment System reduces intraocular pressure in patients with refractory glaucoma.

Read more 
GSK receives FDA approval for expanded indication for FluLaval Quadrivalent

GSK receives FDA approval for expanded indication for FluLaval Quadrivalent

21 Nov 2016

Indication now includes use in children 6 months and older.

Read more 
Intarcia's NDA tackles glycemic control and poor patient adherence head on

Intarcia's NDA tackles glycemic control and poor patient adherence head on

21 Nov 2016

ITCA 650 is the first investigational drug to use Intarcia's disruptive Medici Drug Delivery System to deliver chronic medicines just once or twice yearly.

Read more 
NICE ‘yes’ for chronic myeloid leukaemia pill

NICE ‘yes’ for chronic myeloid leukaemia pill

17 Nov 2016

For patients this could mean more are able to achieve a normal life expectancy, without compromising on their quality of life.

Read more 
Adherium’s Smartinhaler dramatically improves clinical outcomes and medication adherence in children with asthma

Adherium’s Smartinhaler dramatically improves clinical outcomes and medication adherence in children with asthma

17 Nov 2016

Trial results also provide a cost-saving argument for introducing Smartinhaler into routine practice.

Read more